Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912073244> ?p ?o ?g. }
- W2912073244 endingPage "336" @default.
- W2912073244 startingPage "329" @default.
- W2912073244 abstract "This research aimed to examine the relationship between anti-glutamic acid decarboxylase antibody (GADA) titers and clinical parameters at onset and to clarify the association between clinical severity and GADA titers in GADA-positive fulminant type 1 diabetes. This cross-sectional observational study included 20 cases with GADA-positive fulminant type 1 diabetes (4 cases from our hospital and 16 from cases reported in the literature). The association between GADA titers and clinical parameters [age, sex, body weight, body mass index, period from appearance of any prodromal symptoms to diagnosis, period from development of hyperglycemic symptoms to diagnosis, GADA titer, HbA1c level, blood pH and HCO3– level, serum levels of ketone bodies and pancreatic exocrine enzymes] were analyzed. Spearman’s rank correlation coefficient (rs) was used for the correlation analysis. The results showed that there was a significant inverse correlation between GADA titers and the “period from appearance of any prodromal symptoms to diagnosis” (rs = –0.559, p < 0.05). Moreover, GADA titers were inversely correlated with blood pH and HCO3– level (rs = –0.576, p < 0.05, rs = –0.578, p < 0.05, respectively), and positively correlated with serum levels of total ketone bodies, acetoacetate, and 3-hydroxybutyrate (rs = 0.661, p < 0.05; rs = 0.700, p < 0.05; and rs = 0.782, p < 0.01, respectively). These findings suggest that higher GADA titers may be linked to more severe clinical severity of GADA-positive fulminant type 1 diabetes at onset. This association may be attributed to possible pre-existence of autoimmunity-related β-cell damage before the onset of fulminant type 1 diabetes." @default.
- W2912073244 created "2019-02-21" @default.
- W2912073244 creator A5017888890 @default.
- W2912073244 creator A5027085714 @default.
- W2912073244 creator A5041469856 @default.
- W2912073244 creator A5059378687 @default.
- W2912073244 creator A5066182280 @default.
- W2912073244 creator A5070852409 @default.
- W2912073244 creator A5084079409 @default.
- W2912073244 creator A5088484073 @default.
- W2912073244 date "2019-01-01" @default.
- W2912073244 modified "2023-10-18" @default.
- W2912073244 title "Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes" @default.
- W2912073244 cites W1479705568 @default.
- W2912073244 cites W1625861559 @default.
- W2912073244 cites W1725918626 @default.
- W2912073244 cites W1964761844 @default.
- W2912073244 cites W2048296690 @default.
- W2912073244 cites W2067765762 @default.
- W2912073244 cites W2068144490 @default.
- W2912073244 cites W2070352277 @default.
- W2912073244 cites W2087711091 @default.
- W2912073244 cites W2104430075 @default.
- W2912073244 cites W2150568560 @default.
- W2912073244 cites W2161447870 @default.
- W2912073244 cites W2167313288 @default.
- W2912073244 cites W2169866299 @default.
- W2912073244 cites W2299176942 @default.
- W2912073244 cites W2319062589 @default.
- W2912073244 cites W2326904657 @default.
- W2912073244 cites W2411643559 @default.
- W2912073244 cites W2790099571 @default.
- W2912073244 cites W2891206686 @default.
- W2912073244 doi "https://doi.org/10.1507/endocrj.ej18-0417" @default.
- W2912073244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30760658" @default.
- W2912073244 hasPublicationYear "2019" @default.
- W2912073244 type Work @default.
- W2912073244 sameAs 2912073244 @default.
- W2912073244 citedByCount "3" @default.
- W2912073244 countsByYear W29120732442019 @default.
- W2912073244 countsByYear W29120732442020 @default.
- W2912073244 crossrefType "journal-article" @default.
- W2912073244 hasAuthorship W2912073244A5017888890 @default.
- W2912073244 hasAuthorship W2912073244A5027085714 @default.
- W2912073244 hasAuthorship W2912073244A5041469856 @default.
- W2912073244 hasAuthorship W2912073244A5059378687 @default.
- W2912073244 hasAuthorship W2912073244A5066182280 @default.
- W2912073244 hasAuthorship W2912073244A5070852409 @default.
- W2912073244 hasAuthorship W2912073244A5084079409 @default.
- W2912073244 hasAuthorship W2912073244A5088484073 @default.
- W2912073244 hasBestOaLocation W29120732441 @default.
- W2912073244 hasConcept C101601086 @default.
- W2912073244 hasConcept C119857082 @default.
- W2912073244 hasConcept C126322002 @default.
- W2912073244 hasConcept C134018914 @default.
- W2912073244 hasConcept C159654299 @default.
- W2912073244 hasConcept C181199279 @default.
- W2912073244 hasConcept C203014093 @default.
- W2912073244 hasConcept C2777180221 @default.
- W2912073244 hasConcept C2781107259 @default.
- W2912073244 hasConcept C31532488 @default.
- W2912073244 hasConcept C32611913 @default.
- W2912073244 hasConcept C41008148 @default.
- W2912073244 hasConcept C55493867 @default.
- W2912073244 hasConcept C555293320 @default.
- W2912073244 hasConcept C62231903 @default.
- W2912073244 hasConcept C71924100 @default.
- W2912073244 hasConcept C86803240 @default.
- W2912073244 hasConcept C90924648 @default.
- W2912073244 hasConcept C9497952 @default.
- W2912073244 hasConceptScore W2912073244C101601086 @default.
- W2912073244 hasConceptScore W2912073244C119857082 @default.
- W2912073244 hasConceptScore W2912073244C126322002 @default.
- W2912073244 hasConceptScore W2912073244C134018914 @default.
- W2912073244 hasConceptScore W2912073244C159654299 @default.
- W2912073244 hasConceptScore W2912073244C181199279 @default.
- W2912073244 hasConceptScore W2912073244C203014093 @default.
- W2912073244 hasConceptScore W2912073244C2777180221 @default.
- W2912073244 hasConceptScore W2912073244C2781107259 @default.
- W2912073244 hasConceptScore W2912073244C31532488 @default.
- W2912073244 hasConceptScore W2912073244C32611913 @default.
- W2912073244 hasConceptScore W2912073244C41008148 @default.
- W2912073244 hasConceptScore W2912073244C55493867 @default.
- W2912073244 hasConceptScore W2912073244C555293320 @default.
- W2912073244 hasConceptScore W2912073244C62231903 @default.
- W2912073244 hasConceptScore W2912073244C71924100 @default.
- W2912073244 hasConceptScore W2912073244C86803240 @default.
- W2912073244 hasConceptScore W2912073244C90924648 @default.
- W2912073244 hasConceptScore W2912073244C9497952 @default.
- W2912073244 hasIssue "4" @default.
- W2912073244 hasLocation W29120732441 @default.
- W2912073244 hasLocation W29120732442 @default.
- W2912073244 hasOpenAccess W2912073244 @default.
- W2912073244 hasPrimaryLocation W29120732441 @default.
- W2912073244 hasRelatedWork W1989244851 @default.
- W2912073244 hasRelatedWork W1990179580 @default.
- W2912073244 hasRelatedWork W1990451414 @default.
- W2912073244 hasRelatedWork W2005354325 @default.